People suffering from arthritis will soon have a new over-the-counter treatment option. Voltaren Arthritis Pain, a non-steroidal anti-inflammatory topical gel, has been approved for over-the-counter ...

WARREN, N.J., May 3, 2021 /PRNewswire/ -- GSK Consumer Healthcare (LSE/NYSE: GSK), the makers of Voltaren Arthritis Pain Gel (diclofenac sodium topical gel, 1%) today revealed new data that uncovers a ...

The FDA has approved Voltaren Arthritis Pain for nonprescription, over-the-counter use, according to a press release. Voltaren (diclofenac sodium topical gel 1%, GlaxoSmithKline), a NSAID previously ...

GlaxoSmithKline’s Voltaren Arthritis Pain Gel, which was formerly a prescription drug, can now be purchased over-the-counter, the company announced Tuesday. The treatment has been available as a ...

Warren-based GlaxoSmithKline announced on Monday the U.S. Food and Drug Administration (FDA) approved Voltaren Arthritis Pain (diclofenac sodium topical gel, 1 percent arthritis pain reliever) as an ...

As it promotes the OTC availability of its recent Rx-to-OTX switch Voltaren Arthritis Pain, GSK Consumer Healthcare is bringing in a big name. The company is teaming up with Paula Abdul, who uses the ...

First US approval for a prescription NSAID (non-steroidal anti-inflammatory drug) treatment that can be applied directly to site of osteoarthritis pain Voltaren Gel is the only prescription topical ...

Voltaren Arthritis Pain Gel aims to help America’s huge unpaid caregiver population through two initiatives: videos of exercises to help ease pain from fitness instructor Amanda Kloots, co-host of CBS ...

Dr. Reddy’s is offering over-the-counter diclofenac sodium topical gel 1%, the store brand version of GSK Consumer Healthcare's Voltaren Arthritis Pain. “The launch of Dr. Reddy’s diclofenac sodium ...

Voltaren Arthritis Pain Gel partners with music superstar Paula Abdul to launch the first and only prescription-strength NSAID gel for arthritis pain available OTC WARREN, N.J., June 11, 2020 ...

WARREN, N.J., Feb. 17, 2020 /PRNewswire/ -- GlaxoSmithKline (LSE/NYSE: GSK) today announced that the U.S. Food and Drug Administration (FDA) has approved Voltaren Arthritis Pain (diclofenac sodium ...